KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 72 filers reported holding KRONOS BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $8,154,000 | -35.2% | 600,000 | 0.0% | 0.00% | -33.3% |
Q3 2021 | $12,576,000 | -12.5% | 600,000 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $14,370,000 | -18.2% | 600,000 | 0.0% | 0.00% | -25.0% |
Q1 2021 | $17,562,000 | -2.0% | 600,000 | 0.0% | 0.00% | -20.0% |
Q4 2020 | $17,922,000 | – | 600,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,765,314 | $9,264,000 | 8.31% |
Omega Fund Management, LLC | 3,818,283 | $12,791,000 | 4.68% |
Privium Fund Management (UK) Ltd | 645,331 | $2,162,000 | 2.76% |
Wildcat Capital Management, LLC | 1,438,232 | $4,818,000 | 1.85% |
Nextech Invest Ltd. | 1,451,537 | $4,863,000 | 1.57% |
Alphabet Inc. | 1,438,232 | $4,818,000 | 0.25% |
Artal Group S.A. | 1,542,954 | $5,169,000 | 0.22% |
Perceptive Advisors | 2,156,151 | $7,223,000 | 0.21% |
Oasis Management Co Ltd. | 196,078 | $657,000 | 0.11% |
PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $1,767,000 | 0.10% |